Metraipolis › archive › dc_21c84ea3759d
Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective… — Europe PMC PMID:41430103
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41430103
- DOI
- 10.1186/s10194-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T11:16:51.065Z
- SHA-256 of the archived text
e1b2ca84aaa6bce839de83eabf8a6c0b2c76edd8c4d7aab462dfb957ac57b482- Stable URL of this page
https://metraipolis.com/documento/dc_21c84ea3759d
How to cite
Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective… — Europe PMC PMID:41430103 — Europe PMC (en), https://europepmc.org/article/MED/41430103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_21c84ea3759d (Metraipolis archive dc_21c84ea3759d, sha256 e1b2ca84aaa6bce839de83eabf8a6c0b2c76edd8c4d7aab462dfb957ac57b482)
BibTeX
@misc{dc21c84ea3759d,
title = {Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective… — Europe PMC PMID:41430103},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41430103},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_21c84ea3759d; sha256 e1b2ca84aaa6bce839de83eabf8a6c0b2c76edd8c4d7aab462dfb957ac57b482},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41430103. Agents can read the archived copy with the MCP tool read_document.